Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

GK1 Inhibitors

GK1 inhibitors belong to a distinctive chemical class primarily designed to modulate the activity of the enzyme glycerol kinase 1 (GK1). Glycerol kinase is a crucial enzyme in the glycerol metabolism pathway, playing a central role in the conversion of glycerol to glycerol-3-phosphate. The inhibition of GK1 is of particular interest due to its involvement in various metabolic processes, including gluconeogenesis, glyceroneogenesis, and adipose tissue lipolysis. The chemical structure of GK1 inhibitors is characterized by specific molecular features that enable them to interact selectively with the active site of the glycerol kinase enzyme. The mechanism of action of GK1 inhibitors involves disrupting the normal catalytic function of the glycerol kinase enzyme, thereby impeding the conversion of glycerol to glycerol-3-phosphate. This inhibition can have downstream effects on metabolic pathways that rely on glycerol-3-phosphate as a substrate. The design of GK1 inhibitors often involves a detailed understanding of the enzyme's structure-activity relationship, with researchers aiming to create compounds that can bind specifically to the active site of glycerol kinase.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a potent kinase inhibitor that can inhibit a broad spectrum of kinases including GK1 by binding to the ATP binding pocket, preventing ATP from phosphorylating substrates.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin binds to FKBP12 and the complex inhibits mTOR, a kinase downstream of many signal transduction pathways, which may include pathways involving GK1.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor; PI3K is often upstream of various kinases and its inhibition can decrease the activation of proteins including GK1.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 inhibits MEK, which is part of the MAPK/ERK pathway, potentially reducing the activity of downstream kinases such as GK1.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Like PD98059, U0126 is a MEK inhibitor and may indirectly decrease the activation of GK1 if it is part of the MAPK/ERK pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a specific inhibitor of p38 MAP kinase; inhibition of p38 MAPK can affect downstream kinases, potentially including GK1.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is another PI3K inhibitor, and by inhibiting PI3K, it can affect the phosphorylation status and activity of GK1.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of JNK, and by inhibiting JNK activity, it may influence the activity of GK1 if JNK is upstream.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Dasatinib is a Src family kinase inhibitor and can also inhibit other kinases, possibly affecting the activity of GK1.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Imatinib is a BCR-ABL kinase inhibitor and also inhibits other tyrosine kinases, which could impact the signaling pathways involving GK1.